Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ENDRA Life Sciences (NDRA) Equity Average: 2017-2021

Historic Equity Average for ENDRA Life Sciences (NDRA) over the last 5 years, with Sep 2021 value amounting to $14.1 million.

  • ENDRA Life Sciences' Equity Average rose 552.76% to $14.1 million in Q3 2021 from the same period last year, while for Sep 2021 it was $14.1 million, marking a year-over-year increase of 552.76%. This contributed to the annual value of $6.0 million for FY2020, which is 8.37% up from last year.
  • As of Q3 2021, ENDRA Life Sciences' Equity Average stood at $14.1 million, which was down 14.30% from $16.4 million recorded in Q2 2021.
  • In the past 5 years, ENDRA Life Sciences' Equity Average ranged from a high of $16.4 million in Q2 2021 and a low of -$1.1 million during Q1 2017.
  • For the 3-year period, ENDRA Life Sciences' Equity Average averaged around $6.2 million, with its median value being $3.6 million (2020).
  • Per our database at Business Quant, ENDRA Life Sciences' Equity Average slumped by 90.08% in 2018 and then surged by 838.63% in 2021.
  • Over the past 5 years, ENDRA Life Sciences' Equity Average (Quarterly) stood at $6.2 million in 2017, then tumbled by 53.46% to $2.9 million in 2018, then rose by 6.44% to $3.1 million in 2019, then spiked by 70.43% to $5.3 million in 2020, then skyrocketed by 552.76% to $14.1 million in 2021.
  • Its Equity Average stands at $14.1 million for Q3 2021, versus $16.4 million for Q2 2021 and $12.5 million for Q1 2021.